Fourth Amendment to License AgreementLicense Agreement • May 7th, 2019 • REGENXBIO Inc. • Biological products, (no disgnostic substances)
This Fourth Amendment to License Agreement (this “Fourth Amendment”) effective as of April 4, 2019 (this “Fourth Amendment Effective Date”), is made by and between The Trustees of the University of Pennsylvania (“Penn”) and REGENXBIO Inc. (“Company”) (collectively, the “Parties”) and amends the License Agreement between the Parties, which was effective as of February 24, 2009, as subsequently amended by a First Amendment dated March 6, 2009, a Second Amendment dated September 9, 2014, and a Third Amendment dated April 29, 2016 (the “License Agreement”). All capitalized terms used but not defined herein shall have the meaning set forth in the License Agreement.
ARE-MARYLAND NO. 24, LLCREGENXBIO Inc. • May 7th, 2019 • Biological products, (no disgnostic substances)
Reference is made to that certain Lease Agreement dated as of November 1, 2018 (“Lease”) between REGENXBIO Inc., a Delaware corporation, as tenant (“Tenant”), and ARE-Maryland No. 24, LLC, a Delaware limited liability company, as landlord (“Landlord”). Initially capitalized terms not specifically defined in this letter agreement are intended to have the meanings set forth for such terms in the Lease.
Letterhead of REGENXBIO Inc.]Employment Agreement • May 7th, 2019 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland
This Employment Agreement (this “Agreement”) is entered into as of March 6, 2019, by and between Stephen Pakola (the “Employee”) and REGENXBIO Inc., a Delaware corporation (the “Company”) and made effective as of the Commencement Date as herein defined.
